Your browser doesn't support javascript.
loading
Zygotic genome activation by the totipotency pioneer factor Nr5a2.
Gassler, Johanna; Kobayashi, Wataru; Gáspár, Imre; Ruangroengkulrith, Siwat; Mohanan, Adarsh; Gómez Hernández, Laura; Kravchenko, Pavel; Kümmecke, Maximilian; Lalic, Aleksandar; Rifel, Nikita; Ashburn, Robert John; Zaczek, Maciej; Vallot, Antoine; Cuenca Rico, Laura; Ladstätter, Sabrina; Tachibana, Kikuë.
Afiliação
  • Gassler J; Department of Totipotency, Max Planck Institute of Biochemistry (MPIB), Munich, Germany.
  • Kobayashi W; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.
  • Gáspár I; Department of Totipotency, Max Planck Institute of Biochemistry (MPIB), Munich, Germany.
  • Ruangroengkulrith S; Department of Totipotency, Max Planck Institute of Biochemistry (MPIB), Munich, Germany.
  • Mohanan A; Department of Totipotency, Max Planck Institute of Biochemistry (MPIB), Munich, Germany.
  • Gómez Hernández L; Department of Totipotency, Max Planck Institute of Biochemistry (MPIB), Munich, Germany.
  • Kravchenko P; Department of Totipotency, Max Planck Institute of Biochemistry (MPIB), Munich, Germany.
  • Kümmecke M; Department of Totipotency, Max Planck Institute of Biochemistry (MPIB), Munich, Germany.
  • Lalic A; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.
  • Rifel N; Department of Totipotency, Max Planck Institute of Biochemistry (MPIB), Munich, Germany.
  • Ashburn RJ; Department of Totipotency, Max Planck Institute of Biochemistry (MPIB), Munich, Germany.
  • Zaczek M; Department of Totipotency, Max Planck Institute of Biochemistry (MPIB), Munich, Germany.
  • Vallot A; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.
  • Cuenca Rico L; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.
  • Ladstätter S; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.
  • Tachibana K; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria.
Science ; 378(6626): 1305-1315, 2022 12 23.
Article em En | MEDLINE | ID: mdl-36423263
Life begins with a switch in genetic control from the maternal to the embryonic genome during zygotic genome activation (ZGA). Despite its importance, the essential regulators of ZGA remain largely unknown in mammals. On the basis of de novo motif searches, we identified the orphan nuclear receptor Nr5a2 as a key activator of major ZGA in mouse two-cell embryos. Nr5a2 is required for progression beyond the two-cell stage. It binds to its motif within SINE B1/Alu retrotransposable elements found in cis-regulatory regions of ZGA genes. Chemical inhibition suggests that 72% of ZGA genes are regulated by Nr5a2 and potentially other orphan nuclear receptors. Nr5a2 promotes chromatin accessibility during ZGA and binds nucleosomal DNA in vitro. We conclude that Nr5a2 is an essential pioneer factor that regulates ZGA.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Zigoto / Desenvolvimento Embrionário Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Zigoto / Desenvolvimento Embrionário Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article